Sanjay Inamdar
Head – International Business, ELMAS

Through my engagements at global MedTech forums, one shift is clear—India is increasingly seen not just as a manufacturing hub, but as a strategic partner in innovation and healthcare delivery.

The global MedTech landscape is evolving rapidly, driven by regulatory convergence, technological advancements, and a growing emphasis on patient-centric care. India’s ecosystem, supported by progressive policy initiatives and a strong entrepreneurial base, is well-positioned to benefit. However, the real opportunity lies in aligning innovation with global regulatory expectations and market access pathways.

At ELMAS, we work at this intersection—enabling companies to navigate complex regulatory environments, accelerate product registrations, and expand into international markets. We support Indian manufacturers in scaling globally while also assisting global organizations entering emerging markets.

India stands at a defining juncture. With the right focus on quality, compliance, and innovation, it has the potential to not only participate in but shape the global MedTech ecosystem.

The way forward lies in stronger collaboration between industry, regulators, and strategic partners. This alignment will be key to driving sustainable growth, improving patient access, and positioning India as a global MedTech leader.